Released : January 12, 2018 17:13 RNS Number : 7976B MaxCyte, Inc. 12 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 12 January 2018: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 18,293 new shares of common
Released : November 30, 2017 15:26 RNS Number : 0291Y MaxCyte, Inc. 30 November 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 30 November 2017: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 41,121 new shares of common
Released : October 31, 2017 12:47 RNS Number : 1243V MaxCyte, Inc. 31 October 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Result of AGM Maryland, USA - 31 October 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration of the discovery, development,
Released : October 16, 2017 07:00 RNS Number : 6267T MaxCyte, Inc. 16 October 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Declaration of Audit Remuneration Maryland, USA - 16 October 2017: MaxCyte (LSE: MXCT, MXCR), in order to assist investors in considering the resolutions
Released : October 05, 2017 18:32 RNS Number : 8773S MaxCyte, Inc. 05 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Released : October 05, 2017 18:31 RNS Number : 8770S MaxCyte, Inc. 05 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Released : September 28, 2017 17:15 RNS Number : 1589S MaxCyte, Inc. 28 September 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Notification of Annual General Meeting Maryland, USA - 28 September 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration
Released : September 19, 2017 07:00 RNS Number : 0903R MaxCyte, Inc. 19 September 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Results for the Six Months ended 30 June 2017 Maryland, USA - 19 September 2017 - MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the
Released : August 25, 2017 07:00 RNS Number : 9391O MaxCyte, Inc. 25 August 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Notice of Half Year Results Maryland, USA - 25 August 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration of the discovery,
Released : July 20, 2017 18:02 RNS Number : 6906L MaxCyte, Inc. 20 July 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Grant of Options Maryland, USA - 20 July 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company dedicated to driving the acceleration of the discovery,
